Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2018 | 2 |
2019 | 3 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
The Humoral Immune Response Against the gB Vaccine: Lessons Learnt from Protection in Solid Organ Transplantation.
Vaccines (Basel). 2019 Jul 17;7(3):67. doi: 10.3390/vaccines7030067.
Vaccines (Basel). 2019.
PMID: 31319553
Free PMC article.
Review.
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.
Nelson CS, Baraniak I, Lilleri D, Reeves MB, Griffiths PD, Permar SR.
Nelson CS, et al.
J Infect Dis. 2020 Mar 5;221(Suppl 1):S45-S59. doi: 10.1093/infdis/jiz428.
J Infect Dis. 2020.
PMID: 32134477
Free PMC article.
Item in Clipboard
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial.
Griffiths PD, Stanton A, McCarrell E, Smith C, Osman M, Harber M, Davenport A, Jones G, Wheeler DC, O'Beirne J, Thorburn D, Patch D, Atkinson CE, Pichon S, Sweny P, Lanzman M, Woodford E, Rothwell E, Old N, Kinyanjui R, Haque T, Atabani S, Luck S, Prideaux S, Milne RS, Emery VC, Burroughs AK.
Griffiths PD, et al.
Lancet. 2011 Apr 9;377(9773):1256-63. doi: 10.1016/S0140-6736(11)60136-0.
Lancet. 2011.
PMID: 21481708
Free PMC article.
Clinical Trial.
Item in Clipboard
Original Antigenic Sin Shapes the Immunological Repertoire Evoked by Human Cytomegalovirus Glycoprotein B/MF59 Vaccine in Seropositive Recipients.
Baraniak I, Kern F, Holenya P, Griffiths P, Reeves M.
Baraniak I, et al.
J Infect Dis. 2019 Jun 19;220(2):228-232. doi: 10.1093/infdis/jiz089.
J Infect Dis. 2019.
PMID: 30815685
Free PMC article.
Clinical Trial.
Item in Clipboard
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia.
Baraniak I, Kropff B, McLean GR, Pichon S, Piras-Douce F, Milne RSB, Smith C, Mach M, Griffiths PD, Reeves MB.
Baraniak I, et al.
J Infect Dis. 2018 May 25;217(12):1907-1917. doi: 10.1093/infdis/jiy102.
J Infect Dis. 2018.
PMID: 29528415
Free PMC article.
Item in Clipboard
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation.
Baraniak I, Gomes AC, Sodi I, Langstone T, Rothwell E, Atkinson C, Pichon S, Piras-Douce F, Griffiths PD, Reeves MB.
Baraniak I, et al.
EBioMedicine. 2019 Dec;50:45-54. doi: 10.1016/j.ebiom.2019.11.005. Epub 2019 Nov 15.
EBioMedicine. 2019.
PMID: 31735553
Free PMC article.
Item in Clipboard
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
Baraniak I, Kropff B, Ambrose L, McIntosh M, McLean GR, Pichon S, Atkinson C, Milne RSB, Mach M, Griffiths PD, Reeves MB.
Baraniak I, et al.
Proc Natl Acad Sci U S A. 2018 Jun 12;115(24):6273-6278. doi: 10.1073/pnas.1800224115. Epub 2018 Apr 23.
Proc Natl Acad Sci U S A. 2018.
PMID: 29686064
Free PMC article.
Item in Clipboard
Cite
Cite